LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 307 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $766,000 | +54.7% | 5,026 | +0.9% | 0.01% | +44.4% |
| Q4 2020 | $495,000 | +4.2% | 4,982 | 0.0% | 0.01% | -10.0% |
| Q3 2020 | $475,000 | -14.7% | 4,982 | 0.0% | 0.01% | -23.1% |
| Q2 2020 | $557,000 | +53.9% | 4,982 | 0.0% | 0.01% | +30.0% |
| Q1 2020 | $362,000 | -30.4% | 4,982 | 0.0% | 0.01% | -9.1% |
| Q4 2019 | $520,000 | -4.9% | 4,982 | -9.4% | 0.01% | 0.0% |
| Q3 2019 | $547,000 | -12.9% | 5,500 | 0.0% | 0.01% | -15.4% |
| Q2 2019 | $628,000 | -9.1% | 5,500 | 0.0% | 0.01% | -13.3% |
| Q1 2019 | $691,000 | -48.4% | 5,500 | -22.5% | 0.02% | -6.2% |
| Q4 2018 | $1,338,000 | +80.6% | 7,100 | +163.0% | 0.02% | 0.0% |
| Q3 2018 | $741,000 | – | 2,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
| Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
| VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
| Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
| Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
| Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
| Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
| Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |